Science Group plc Completes 15,000 Share Buyback at 585p Each on 16 July 2026

Details of Share Buyback and Execution Process

On 16 July 2026, Science Group plc carried out a targeted share buyback, acquiring 15,000 of its 1p ordinary shares through its nominated adviser and joint broker Panmure Liberum Limited. The purchase occurred at exactly 11:33:31 on the AIM exchange (AIMX), with all shares bought at a uniform price of 585p. This consistent pricing indicates the shares were acquired as part of a pre-planned tranche within the company’s broader capital allocation strategy. Utilizing Panmure Liberum Limited as the executing broker aligns with standard practices for AIM-listed companies conducting buyback programmes, ensuring adherence to regulatory and market conduct rules.

The buyback reflects Science Group’s approach to capital structure management amid the mid-July 2026 market environment. At 585p per share, the company allocated capital to repurchase shares it considered undervalued relative to fundamental value, while simultaneously reducing shares in active circulation. This strategic treasury purchase approach is common among profitable mid-cap firms aiming to enhance shareholder returns without engaging in larger corporate transactions. Executing the buyback on AIM, London Stock Exchange’s market for smaller companies, highlights Science Group’s profile as a publicly listed specialist investment focused on engineering and science-based services.

Effect on Shareholder Voting Rights and Capital Structure

Following this buyback, Science Group’s outstanding share capital structure has been adjusted, with the number of ordinary shares in issue (excluding treasury shares) now at 40,687,593. This figure serves as the denominator for shareholders calculating notification thresholds under the FCA’s Disclosure Guidance and Transparency Rules, a key factor for substantial shareholders monitoring their holdings. The 15,000 shares repurchased represent 0.04% of total voting rights, indicating a modest tranche within a larger capital management framework. Combined with the company’s treasury holding of 5,498,281 shares, this demonstrates active management of the share base.

The distinction between issued shares and treasury shares is significant for dilution and voting power distribution. By retaining shares in treasury rather than cancelling them, Science Group maintains flexibility to use these shares for future employee incentive schemes, acquisitions, or other corporate purposes without requiring fresh shareholder approval. The treasury reserve of 5,498,281 shares equates to approximately 11.9% of the current issued share count, offering the board substantial optionality. Investors should monitor both the pace of treasury purchases and any deployment of these shares, as these actions will impact future dilution and shareholder value.

Regulatory Compliance and Market Abuse Regulation Adherence

Science Group confirmed full compliance with Article 5(1)(b) of Regulation (EU) No 596/2014 (Market Abuse Regulation, MAR) by publishing detailed information on the individual purchase transaction. This transparency requirement mandates disclosure of the number of shares acquired, price paid, exact time of execution, and trading venue. In this case, the company reported a single consolidated transaction of 15,000 shares at 585p each at 11:33:31 on AIMX. Such detailed disclosure helps prevent market abuse and assures investors that the buyback was conducted at fair market prices without manipulation or insider advantage.

Compliance with MAR is particularly important for AIM-listed companies, which operate under a lighter regulatory regime than the Main Market but still require rigorous standards for share transactions and disclosures. The engagement of Panmure Liberum Limited as executing broker adds independent oversight and ensures compliance with applicable rules. As nominated adviser and joint broker, Panmure Liberum certifies adherence to regulations before executing transactions on behalf of Science Group. This structured approach to disclosure and broker selection signals strong governance and operational discipline.

Treasury Share Accumulation and Strategic Options

Science Group’s treasury holdings now total 5,498,281 shares, representing a significant equity reserve held off-market. This reflects a multi-year selective buyback programme, indicating management’s consistent identification of attractive repurchase opportunities relative to underlying value. Holding shares in treasury rather than cancelling them provides strategic flexibility, allowing the board to use these shares for acquisitions, employee compensation schemes, or capital raises without diluting existing shareholders. This flexibility is valuable in Science Group’s specialist engineering and scientific services sector, where acquisition opportunities may arise requiring swift equity deployment.

The treasury accumulation should be viewed alongside Science Group’s operational performance and cash flow generation. Companies confident in their financial outlook typically commit capital to buybacks. Science Group’s continuation of share repurchases through 2025 and into 2026 reflects management’s conviction in the company’s medium-term prospects and capital efficiency. Investors should interpret buyback trends as indicators of board confidence, with acceleration suggesting perceived undervaluation and pauses potentially signaling reassessment of capital priorities or market conditions.

Company Profile and Sector Overview

Science Group plc is a specialist provider of engineering and scientific consultancy services, delivering technical expertise across diverse industrial and commercial sectors. The company supports clients requiring advanced problem-solving, technology assessment, and project delivery where engineering excellence and scientific rigor are essential. Its business model relies on deploying highly skilled consultants on time-and-materials or fixed-fee contracts, generating revenue from billable hours and project completions. With operations in the UK and internationally, Science Group leverages the portability of technical expertise across borders. Maintaining competitive positioning requires ongoing investment in recruitment, retention, and professional development.

The consultancy and engineering sector has experienced varied dynamics in 2025 and 2026 amid economic uncertainty and fluctuating client capital expenditure. While revenue streams tend to be resilient during expansions as clients invest in innovation, discretionary spending can be curtailed during slower growth or recessions. Science Group’s continued buybacks suggest management believes its exposure to resilient customer segments and the quality of its professional team provide insulation against cyclical downturns. The specialist nature of its services may offer greater pricing stability compared to generalist consultancies, though this warrants monitoring through economic cycles.

Share Price Context and Valuation Insights

The buyback price of 585p per share on 16 July 2026 offers insight into the market valuation at that time, reflecting investor sentiment regarding Science Group’s prospects and financial position. Management’s decision to repurchase shares at this price signals their view that the shares were undervalued relative to intrinsic worth. Investors considering positions in Science Group should weigh this supportive signal alongside other factors, recognizing that buybacks do not guarantee future share price appreciation.

The uniform price paid for all 15,000 shares indicates a single concentrated tranche purchase rather than incremental buys throughout the trading day. This approach may have been designed to minimize market impact and align with pre-agreed broker arrangements. For investors analyzing share price trends and valuation drivers, the 585p buyback price serves as a useful historical reference point. The immediate market reaction was not publicly detailed; investors should review subsequent trading data to assess any price or sentiment effects.

Ongoing Capital Management and Shareholder Implications

The 15,000 share repurchase is part of Science Group’s continuing capital management programme aimed at optimizing shareholder returns. The company typically seeks shareholder authorization at Annual General Meetings to repurchase shares up to specified limits, executing purchases opportunistically based on market conditions and cash availability. The sizeable treasury holding of 5,498,281 shares confirms prior approvals and methodical capital deployment. Shareholders should monitor buyback activity trends as indicators of management’s evolving value assessment and confidence.

Going forward, shareholders may want to track whether Science Group maintains buybacks at similar price levels or adjusts strategy in response to market changes. Additionally, the use or accumulation of treasury shares for acquisitions, employee schemes, or other purposes will impact dilution and capital structure. Dividend policy changes and operational performance will also influence capital return approaches. While the buyback announcement does not directly affect operational results, the pattern of repurchases provides insights into management’s strategic priorities.

Disclosure Requirements and Shareholder Notification Thresholds

Science Group’s announcement specifies that shareholders must use the updated issued share count of 40,687,593 when calculating notification thresholds under FCA rules. Accurate calculation is critical for shareholders crossing disclosure thresholds (e.g., 3%, 5%, 10%) to comply with regulatory notification obligations. Using outdated share counts could lead to inadvertent breaches. The company’s detailed disclosure of transaction time (11:33:31) and venue (AIMX) supports precise shareholder record-keeping and regulatory compliance.

While these technical details may have limited impact for retail investors, institutional shareholders and advisers must carefully incorporate this information to avoid regulatory issues. Science Group’s transparent and timely communication reflects strong corporate governance and helps prevent shareholder confusion or inadvertent non-compliance with disclosure rules.